Tuba Hacibekiroglu

Tuba Hacibekiroglu

Auto-generated profile, based on publicly available information

Tuba Hacibekiroglu

Department of Hematology, Sakarya University Hospital, Medical Faculty, Sakarya, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
FAFevzi Altuntas
Fevzi Altuntas
NANaim Ata
Naim Ata
TYTugce Nur Yigenoglu
Tugce Nur Yigenoglu
SBSemih Başcı
Semih Başcı
MDMehmet Sinan Dal
Mehmet Sinan Dal
OCOsman Celik
Osman Celik

1 December 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
YKYasin Kalpakci
Yasin Kalpakci
THTuba Hacibekiroglu
Tuba Hacibekiroglu
GTGulay Trak
Gulay Trak
CKCengiz Karacaer
Cengiz Karacaer
TDTaner Demi̇rci̇
Taner Demi̇rci̇
MFMesude Falay
Mesude Falay
SUMMARY BACKGROUND: The COVID-19 pandemic has affected the entire world, posing a serious threat to human health. T cells play a critical role in the cellular immune response against viral infections. We aimed to reveal the relationship between T cell subsets and disease severity. METHODS: 40 COVID-19 patients were randomly recruited in this cross-sectional study. All cases were confirmed by quantitative RT-PCR. Patients were divided into two equivalent groups, one severe and one nonsevere. Clinical, laboratory and flow cytometric data were obtained from both clinical groups and compared. RESULTS: Lymphocyte subsets, CD4+ and CD8+ T cells, memory CD4+ T cells, memory CD8+ T cells, naive CD4+ T cells, effector memory CD4+ T cells, central memory CD4+ T cells, and CD3+CD4+ CD25+ T cells were significantly lower in severe patients. The naive T cell/CD4 + EM T cell ratio, which is an indicator of the differentiation from naive T cells to memory cells, was relatively reduced in severe disease. Peripheral CD4+CD8+ double-positive T cells were notably lower in severe presentations of the disease (median DP T cells 11.12 µL vs 1.95 µL; p< 0.001). CONCLUSIONS: As disease severity increases in COVID-19 infection, the number of T cell subsets decreases significantly. Suppression of differentiation from naive T cells to effector memory T cells is the result of severe impairment in adaptive immune functions. Peripheral CD4+CD8+ double-positive T cells were significantly reduced in severe disease presentations and may be a useful marker to predict disease severity.

1 June 2020 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
TYTuğçe Nur Yiğenoğlu
Tuğçe Nur Yiğenoğlu
SBSemih Başcı
Semih Başcı
BUBahar Uncu Ulu
Bahar Uncu Ulu
MBMehmet Bakirtas
Mehmet Bakirtas
AKAli Kılınç
Ali Kılınç
FAFevzi Altuntaş
Fevzi Altuntaş

1 October 2021 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
YKYasin Kalpakci
Yasin Kalpakci
THTuba Hacibekiroglu
Tuba Hacibekiroglu
TDTahir Darcin
Tahir Darcin
GAGulsum AkgunCagliyan
Gulsum AkgunCagliyan
MCMerih Kizil Cakar
Merih Kizil Cakar
FAFevzi Altuntas
Fevzi Altuntas

26 February 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
THTuba Hacibeki̇roğlu
Tuba Hacibeki̇roğlu
YKYasin Kalpakçi
Yasin Kalpakçi
AGAHMED CIHAD GENC
AHMED CIHAD GENC
MHmehmet akif Hacıbekiroğlu
mehmet akif Hacıbekiroğlu
CSCenk SUNU
Cenk SUNU
MKMehmet Koroglu
Mehmet Koroglu
Background/aim: In this study, we aim to investigate the efficacy of convalescent plasma (CP) according to blood groups (BGs) in the treatment of critically ill patients diagnosed with COVID-19. Materials and methods: Twenty-eight critically ill and laboratory-confirmed COVID-19 patients who were admitted to the intensive care unit (ICU) of Sakarya University, Medical Faculty were included in the study. Patients were divided into 2 groups: patients who received anti-A antibody (Ab) containing CP (BG O and B) and those who did not receive CP containing anti-A Ab (BG A and AB). Results: Among the 28 patients, 13 patients received anti-A Ab containing CP (BG; B: 6, O: 7) and 15 patients did not receive anti-A Ab CP (BG; A: 13, AB: 2). Duration in ICU, the rates of mechanical ventilation (MV) support and vasopressor support, the case fatality rate, and the discharge rate were lower in patients who received CP containing anti-A Ab than not containing anti-A Ab CP. However, only the difference in the rate of MV support achieved statistically significance (P = 0.04) Conclusion: In our study, it was observed that the efficiency of CP without anti-A antibody was lower than that of plasma containing anti-A antibody, although it was not statistically significant. This result is thought to be due to the anti-A antibody's ability to block the ACE2 receptor. We believe that this hypothesis should be investigated in controlled studies with higher patient numbers.

1 June 2020 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
TYTuğçe Nur Yiğenoğlu
Tuğçe Nur Yiğenoğlu
SBSemih Başcı
Semih Başcı
MBMehmet Bakirtas
Mehmet Bakirtas
BUBahar Uncu Ulu
Bahar Uncu Ulu
AKAli Kılınç
Ali Kılınç
FAFevzi Altuntaş
Fevzi Altuntaş